Global IBS-C Drugs Market Growth 2025-2031
The global IBS-C Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
United States market for IBS-C Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for IBS-C Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for IBS-C Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key IBS-C Drugs players cover Catalent Pharmaceuticals Solutions, Nestle, Abbott Laboratories, Synergy Pharmaceuticals, Sucampo Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “IBS-C Drugs Industry Forecast” looks at past sales and reviews total world IBS-C Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected IBS-C Drugs sales for 2025 through 2031. With IBS-C Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IBS-C Drugs industry.
This Insight Report provides a comprehensive analysis of the global IBS-C Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IBS-C Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global IBS-C Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IBS-C Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IBS-C Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of IBS-C Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global IBS-C Drugs market?
What factors are driving IBS-C Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do IBS-C Drugs market opportunities vary by end market size?
How does IBS-C Drugs break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
United States market for IBS-C Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for IBS-C Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for IBS-C Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key IBS-C Drugs players cover Catalent Pharmaceuticals Solutions, Nestle, Abbott Laboratories, Synergy Pharmaceuticals, Sucampo Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “IBS-C Drugs Industry Forecast” looks at past sales and reviews total world IBS-C Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected IBS-C Drugs sales for 2025 through 2031. With IBS-C Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IBS-C Drugs industry.
This Insight Report provides a comprehensive analysis of the global IBS-C Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IBS-C Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global IBS-C Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IBS-C Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IBS-C Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of IBS-C Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Linaclotide
- Lubiprostone
- Osmotic Laxatives
- Stimulant Laxatives
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Catalent Pharmaceuticals Solutions
- Nestle
- Abbott Laboratories
- Synergy Pharmaceuticals
- Sucampo Pharmaceuticals
- Novartis Pharma Ag
- Astellas Pharmaceuticals
- Ardelyx, Inc
- Synthetic Biologics, Inc
- Teva Pharmaceutical Industries
- Bama-Geve, SLU
- Ferring BV
- Ironwood Pharmaceuticals, Inc
- Salix Pharmaceuticals Ltd
- Norgine B.V
- Prometheus Laboratories Inc
- Actavis Nordic A/S
- Albireo Pharma Inc
- Yuhan Corp
- Astrazeneca Plc
- The Menarini Group
- Ono Pharmaceutical Co., Ltd
What is the 10-year outlook for the global IBS-C Drugs market?
What factors are driving IBS-C Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do IBS-C Drugs market opportunities vary by end market size?
How does IBS-C Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bone Glues Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Bone Glues by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Bone Glues by Country/Region, 2020, 2024 & 2031
2.2 Bone Glues Segment by Type
2.2.1 PMMA
2.2.2 Calcium Phosphate
2.2.3 Natural
2.2.4 Synthetic
2.3 Bone Glues Sales by Type
2.3.1 Global Bone Glues Sales Market Share by Type (2020-2025)
2.3.2 Global Bone Glues Revenue and Market Share by Type (2020-2025)
2.3.3 Global Bone Glues Sale Price by Type (2020-2025)
2.4 Bone Glues Segment by Application
2.4.1 Arthroplasty
2.4.2 Kyphoplasty
2.4.3 Vertebroplasty
2.5 Bone Glues Sales by Application
2.5.1 Global Bone Glues Sale Market Share by Application (2020-2025)
2.5.2 Global Bone Glues Revenue and Market Share by Application (2020-2025)
2.5.3 Global Bone Glues Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Bone Glues Breakdown Data by Company
3.1.1 Global Bone Glues Annual Sales by Company (2020-2025)
3.1.2 Global Bone Glues Sales Market Share by Company (2020-2025)
3.2 Global Bone Glues Annual Revenue by Company (2020-2025)
3.2.1 Global Bone Glues Revenue by Company (2020-2025)
3.2.2 Global Bone Glues Revenue Market Share by Company (2020-2025)
3.3 Global Bone Glues Sale Price by Company
3.4 Key Manufacturers Bone Glues Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bone Glues Product Location Distribution
3.4.2 Players Bone Glues Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BONE GLUES BY GEOGRAPHIC REGION
4.1 World Historic Bone Glues Market Size by Geographic Region (2020-2025)
4.1.1 Global Bone Glues Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Bone Glues Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Bone Glues Market Size by Country/Region (2020-2025)
4.2.1 Global Bone Glues Annual Sales by Country/Region (2020-2025)
4.2.2 Global Bone Glues Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bone Glues Sales Growth
4.4 APAC Bone Glues Sales Growth
4.5 Europe Bone Glues Sales Growth
4.6 Middle East & Africa Bone Glues Sales Growth
5 AMERICAS
5.1 Americas Bone Glues Sales by Country
5.1.1 Americas Bone Glues Sales by Country (2020-2025)
5.1.2 Americas Bone Glues Revenue by Country (2020-2025)
5.2 Americas Bone Glues Sales by Type (2020-2025)
5.3 Americas Bone Glues Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bone Glues Sales by Region
6.1.1 APAC Bone Glues Sales by Region (2020-2025)
6.1.2 APAC Bone Glues Revenue by Region (2020-2025)
6.2 APAC Bone Glues Sales by Type (2020-2025)
6.3 APAC Bone Glues Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Bone Glues by Country
7.1.1 Europe Bone Glues Sales by Country (2020-2025)
7.1.2 Europe Bone Glues Revenue by Country (2020-2025)
7.2 Europe Bone Glues Sales by Type (2020-2025)
7.3 Europe Bone Glues Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bone Glues by Country
8.1.1 Middle East & Africa Bone Glues Sales by Country (2020-2025)
8.1.2 Middle East & Africa Bone Glues Revenue by Country (2020-2025)
8.2 Middle East & Africa Bone Glues Sales by Type (2020-2025)
8.3 Middle East & Africa Bone Glues Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bone Glues
10.3 Manufacturing Process Analysis of Bone Glues
10.4 Industry Chain Structure of Bone Glues
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bone Glues Distributors
11.3 Bone Glues Customer
12 WORLD FORECAST REVIEW FOR BONE GLUES BY GEOGRAPHIC REGION
12.1 Global Bone Glues Market Size Forecast by Region
12.1.1 Global Bone Glues Forecast by Region (2026-2031)
12.1.2 Global Bone Glues Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Bone Glues Forecast by Type (2026-2031)
12.7 Global Bone Glues Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Stryker
13.1.1 Stryker Company Information
13.1.2 Stryker Bone Glues Product Portfolios and Specifications
13.1.3 Stryker Bone Glues Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Stryker Main Business Overview
13.1.5 Stryker Latest Developments
13.2 DePuy Synthes
13.2.1 DePuy Synthes Company Information
13.2.2 DePuy Synthes Bone Glues Product Portfolios and Specifications
13.2.3 DePuy Synthes Bone Glues Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 DePuy Synthes Main Business Overview
13.2.5 DePuy Synthes Latest Developments
13.3 Smith & Nephew
13.3.1 Smith & Nephew Company Information
13.3.2 Smith & Nephew Bone Glues Product Portfolios and Specifications
13.3.3 Smith & Nephew Bone Glues Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Smith & Nephew Main Business Overview
13.3.5 Smith & Nephew Latest Developments
13.4 Arthrex
13.4.1 Arthrex Company Information
13.4.2 Arthrex Bone Glues Product Portfolios and Specifications
13.4.3 Arthrex Bone Glues Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Arthrex Main Business Overview
13.4.5 Arthrex Latest Developments
13.5 DJO Global
13.5.1 DJO Global Company Information
13.5.2 DJO Global Bone Glues Product Portfolios and Specifications
13.5.3 DJO Global Bone Glues Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 DJO Global Main Business Overview
13.5.5 DJO Global Latest Developments
13.6 Exactech
13.6.1 Exactech Company Information
13.6.2 Exactech Bone Glues Product Portfolios and Specifications
13.6.3 Exactech Bone Glues Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Exactech Main Business Overview
13.6.5 Exactech Latest Developments
13.7 TEKNIMED
13.7.1 TEKNIMED Company Information
13.7.2 TEKNIMED Bone Glues Product Portfolios and Specifications
13.7.3 TEKNIMED Bone Glues Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 TEKNIMED Main Business Overview
13.7.5 TEKNIMED Latest Developments
13.8 Cardinal Health
13.8.1 Cardinal Health Company Information
13.8.2 Cardinal Health Bone Glues Product Portfolios and Specifications
13.8.3 Cardinal Health Bone Glues Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Cardinal Health Main Business Overview
13.8.5 Cardinal Health Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bone Glues Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Bone Glues by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Bone Glues by Country/Region, 2020, 2024 & 2031
2.2 Bone Glues Segment by Type
2.2.1 PMMA
2.2.2 Calcium Phosphate
2.2.3 Natural
2.2.4 Synthetic
2.3 Bone Glues Sales by Type
2.3.1 Global Bone Glues Sales Market Share by Type (2020-2025)
2.3.2 Global Bone Glues Revenue and Market Share by Type (2020-2025)
2.3.3 Global Bone Glues Sale Price by Type (2020-2025)
2.4 Bone Glues Segment by Application
2.4.1 Arthroplasty
2.4.2 Kyphoplasty
2.4.3 Vertebroplasty
2.5 Bone Glues Sales by Application
2.5.1 Global Bone Glues Sale Market Share by Application (2020-2025)
2.5.2 Global Bone Glues Revenue and Market Share by Application (2020-2025)
2.5.3 Global Bone Glues Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Bone Glues Breakdown Data by Company
3.1.1 Global Bone Glues Annual Sales by Company (2020-2025)
3.1.2 Global Bone Glues Sales Market Share by Company (2020-2025)
3.2 Global Bone Glues Annual Revenue by Company (2020-2025)
3.2.1 Global Bone Glues Revenue by Company (2020-2025)
3.2.2 Global Bone Glues Revenue Market Share by Company (2020-2025)
3.3 Global Bone Glues Sale Price by Company
3.4 Key Manufacturers Bone Glues Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bone Glues Product Location Distribution
3.4.2 Players Bone Glues Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BONE GLUES BY GEOGRAPHIC REGION
4.1 World Historic Bone Glues Market Size by Geographic Region (2020-2025)
4.1.1 Global Bone Glues Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Bone Glues Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Bone Glues Market Size by Country/Region (2020-2025)
4.2.1 Global Bone Glues Annual Sales by Country/Region (2020-2025)
4.2.2 Global Bone Glues Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bone Glues Sales Growth
4.4 APAC Bone Glues Sales Growth
4.5 Europe Bone Glues Sales Growth
4.6 Middle East & Africa Bone Glues Sales Growth
5 AMERICAS
5.1 Americas Bone Glues Sales by Country
5.1.1 Americas Bone Glues Sales by Country (2020-2025)
5.1.2 Americas Bone Glues Revenue by Country (2020-2025)
5.2 Americas Bone Glues Sales by Type (2020-2025)
5.3 Americas Bone Glues Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bone Glues Sales by Region
6.1.1 APAC Bone Glues Sales by Region (2020-2025)
6.1.2 APAC Bone Glues Revenue by Region (2020-2025)
6.2 APAC Bone Glues Sales by Type (2020-2025)
6.3 APAC Bone Glues Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Bone Glues by Country
7.1.1 Europe Bone Glues Sales by Country (2020-2025)
7.1.2 Europe Bone Glues Revenue by Country (2020-2025)
7.2 Europe Bone Glues Sales by Type (2020-2025)
7.3 Europe Bone Glues Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bone Glues by Country
8.1.1 Middle East & Africa Bone Glues Sales by Country (2020-2025)
8.1.2 Middle East & Africa Bone Glues Revenue by Country (2020-2025)
8.2 Middle East & Africa Bone Glues Sales by Type (2020-2025)
8.3 Middle East & Africa Bone Glues Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bone Glues
10.3 Manufacturing Process Analysis of Bone Glues
10.4 Industry Chain Structure of Bone Glues
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bone Glues Distributors
11.3 Bone Glues Customer
12 WORLD FORECAST REVIEW FOR BONE GLUES BY GEOGRAPHIC REGION
12.1 Global Bone Glues Market Size Forecast by Region
12.1.1 Global Bone Glues Forecast by Region (2026-2031)
12.1.2 Global Bone Glues Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Bone Glues Forecast by Type (2026-2031)
12.7 Global Bone Glues Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Stryker
13.1.1 Stryker Company Information
13.1.2 Stryker Bone Glues Product Portfolios and Specifications
13.1.3 Stryker Bone Glues Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Stryker Main Business Overview
13.1.5 Stryker Latest Developments
13.2 DePuy Synthes
13.2.1 DePuy Synthes Company Information
13.2.2 DePuy Synthes Bone Glues Product Portfolios and Specifications
13.2.3 DePuy Synthes Bone Glues Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 DePuy Synthes Main Business Overview
13.2.5 DePuy Synthes Latest Developments
13.3 Smith & Nephew
13.3.1 Smith & Nephew Company Information
13.3.2 Smith & Nephew Bone Glues Product Portfolios and Specifications
13.3.3 Smith & Nephew Bone Glues Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Smith & Nephew Main Business Overview
13.3.5 Smith & Nephew Latest Developments
13.4 Arthrex
13.4.1 Arthrex Company Information
13.4.2 Arthrex Bone Glues Product Portfolios and Specifications
13.4.3 Arthrex Bone Glues Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Arthrex Main Business Overview
13.4.5 Arthrex Latest Developments
13.5 DJO Global
13.5.1 DJO Global Company Information
13.5.2 DJO Global Bone Glues Product Portfolios and Specifications
13.5.3 DJO Global Bone Glues Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 DJO Global Main Business Overview
13.5.5 DJO Global Latest Developments
13.6 Exactech
13.6.1 Exactech Company Information
13.6.2 Exactech Bone Glues Product Portfolios and Specifications
13.6.3 Exactech Bone Glues Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Exactech Main Business Overview
13.6.5 Exactech Latest Developments
13.7 TEKNIMED
13.7.1 TEKNIMED Company Information
13.7.2 TEKNIMED Bone Glues Product Portfolios and Specifications
13.7.3 TEKNIMED Bone Glues Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 TEKNIMED Main Business Overview
13.7.5 TEKNIMED Latest Developments
13.8 Cardinal Health
13.8.1 Cardinal Health Company Information
13.8.2 Cardinal Health Bone Glues Product Portfolios and Specifications
13.8.3 Cardinal Health Bone Glues Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Cardinal Health Main Business Overview
13.8.5 Cardinal Health Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. IBS-C Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. IBS-C Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Linaclotide
Table 4. Major Players of Lubiprostone
Table 5. Major Players of Osmotic Laxatives
Table 6. Major Players of Stimulant Laxatives
Table 7. Major Players of Others
Table 8. Global IBS-C Drugs Sales by Type (2020-2025) & (K Pcs)
Table 9. Global IBS-C Drugs Sales Market Share by Type (2020-2025)
Table 10. Global IBS-C Drugs Revenue by Type (2020-2025) & ($ million)
Table 11. Global IBS-C Drugs Revenue Market Share by Type (2020-2025)
Table 12. Global IBS-C Drugs Sale Price by Type (2020-2025) & (USD/Pcs)
Table 13. Global IBS-C Drugs Sale by Application (2020-2025) & (K Pcs)
Table 14. Global IBS-C Drugs Sale Market Share by Application (2020-2025)
Table 15. Global IBS-C Drugs Revenue by Application (2020-2025) & ($ million)
Table 16. Global IBS-C Drugs Revenue Market Share by Application (2020-2025)
Table 17. Global IBS-C Drugs Sale Price by Application (2020-2025) & (USD/Pcs)
Table 18. Global IBS-C Drugs Sales by Company (2020-2025) & (K Pcs)
Table 19. Global IBS-C Drugs Sales Market Share by Company (2020-2025)
Table 20. Global IBS-C Drugs Revenue by Company (2020-2025) & ($ millions)
Table 21. Global IBS-C Drugs Revenue Market Share by Company (2020-2025)
Table 22. Global IBS-C Drugs Sale Price by Company (2020-2025) & (USD/Pcs)
Table 23. Key Manufacturers IBS-C Drugs Producing Area Distribution and Sales Area
Table 24. Players IBS-C Drugs Products Offered
Table 25. IBS-C Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global IBS-C Drugs Sales by Geographic Region (2020-2025) & (K Pcs)
Table 29. Global IBS-C Drugs Sales Market Share Geographic Region (2020-2025)
Table 30. Global IBS-C Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global IBS-C Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global IBS-C Drugs Sales by Country/Region (2020-2025) & (K Pcs)
Table 33. Global IBS-C Drugs Sales Market Share by Country/Region (2020-2025)
Table 34. Global IBS-C Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global IBS-C Drugs Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas IBS-C Drugs Sales by Country (2020-2025) & (K Pcs)
Table 37. Americas IBS-C Drugs Sales Market Share by Country (2020-2025)
Table 38. Americas IBS-C Drugs Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas IBS-C Drugs Sales by Type (2020-2025) & (K Pcs)
Table 40. Americas IBS-C Drugs Sales by Application (2020-2025) & (K Pcs)
Table 41. APAC IBS-C Drugs Sales by Region (2020-2025) & (K Pcs)
Table 42. APAC IBS-C Drugs Sales Market Share by Region (2020-2025)
Table 43. APAC IBS-C Drugs Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC IBS-C Drugs Sales by Type (2020-2025) & (K Pcs)
Table 45. APAC IBS-C Drugs Sales by Application (2020-2025) & (K Pcs)
Table 46. Europe IBS-C Drugs Sales by Country (2020-2025) & (K Pcs)
Table 47. Europe IBS-C Drugs Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe IBS-C Drugs Sales by Type (2020-2025) & (K Pcs)
Table 49. Europe IBS-C Drugs Sales by Application (2020-2025) & (K Pcs)
Table 50. Middle East & Africa IBS-C Drugs Sales by Country (2020-2025) & (K Pcs)
Table 51. Middle East & Africa IBS-C Drugs Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa IBS-C Drugs Sales by Type (2020-2025) & (K Pcs)
Table 53. Middle East & Africa IBS-C Drugs Sales by Application (2020-2025) & (K Pcs)
Table 54. Key Market Drivers & Growth Opportunities of IBS-C Drugs
Table 55. Key Market Challenges & Risks of IBS-C Drugs
Table 56. Key Industry Trends of IBS-C Drugs
Table 57. IBS-C Drugs Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. IBS-C Drugs Distributors List
Table 60. IBS-C Drugs Customer List
Table 61. Global IBS-C Drugs Sales Forecast by Region (2026-2031) & (K Pcs)
Table 62. Global IBS-C Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas IBS-C Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
Table 64. Americas IBS-C Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC IBS-C Drugs Sales Forecast by Region (2026-2031) & (K Pcs)
Table 66. APAC IBS-C Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe IBS-C Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Europe IBS-C Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa IBS-C Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
Table 70. Middle East & Africa IBS-C Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global IBS-C Drugs Sales Forecast by Type (2026-2031) & (K Pcs)
Table 72. Global IBS-C Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global IBS-C Drugs Sales Forecast by Application (2026-2031) & (K Pcs)
Table 74. Global IBS-C Drugs Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Catalent Pharmaceuticals Solutions Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 76. Catalent Pharmaceuticals Solutions IBS-C Drugs Product Portfolios and Specifications
Table 77. Catalent Pharmaceuticals Solutions IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Catalent Pharmaceuticals Solutions Main Business
Table 79. Catalent Pharmaceuticals Solutions Latest Developments
Table 80. Nestle Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Nestle IBS-C Drugs Product Portfolios and Specifications
Table 82. Nestle IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Nestle Main Business
Table 84. Nestle Latest Developments
Table 85. Abbott Laboratories Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Abbott Laboratories IBS-C Drugs Product Portfolios and Specifications
Table 87. Abbott Laboratories IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Abbott Laboratories Main Business
Table 89. Abbott Laboratories Latest Developments
Table 90. Synergy Pharmaceuticals Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Synergy Pharmaceuticals IBS-C Drugs Product Portfolios and Specifications
Table 92. Synergy Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Synergy Pharmaceuticals Main Business
Table 94. Synergy Pharmaceuticals Latest Developments
Table 95. Sucampo Pharmaceuticals Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Sucampo Pharmaceuticals IBS-C Drugs Product Portfolios and Specifications
Table 97. Sucampo Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Sucampo Pharmaceuticals Main Business
Table 99. Sucampo Pharmaceuticals Latest Developments
Table 100. Novartis Pharma Ag Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Novartis Pharma Ag IBS-C Drugs Product Portfolios and Specifications
Table 102. Novartis Pharma Ag IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Novartis Pharma Ag Main Business
Table 104. Novartis Pharma Ag Latest Developments
Table 105. Astellas Pharmaceuticals Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Astellas Pharmaceuticals IBS-C Drugs Product Portfolios and Specifications
Table 107. Astellas Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Astellas Pharmaceuticals Main Business
Table 109. Astellas Pharmaceuticals Latest Developments
Table 110. Ardelyx, Inc Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Ardelyx, Inc IBS-C Drugs Product Portfolios and Specifications
Table 112. Ardelyx, Inc IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Ardelyx, Inc Main Business
Table 114. Ardelyx, Inc Latest Developments
Table 115. Synthetic Biologics, Inc Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Synthetic Biologics, Inc IBS-C Drugs Product Portfolios and Specifications
Table 117. Synthetic Biologics, Inc IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Synthetic Biologics, Inc Main Business
Table 119. Synthetic Biologics, Inc Latest Developments
Table 120. Teva Pharmaceutical Industries Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Teva Pharmaceutical Industries IBS-C Drugs Product Portfolios and Specifications
Table 122. Teva Pharmaceutical Industries IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Teva Pharmaceutical Industries Main Business
Table 124. Teva Pharmaceutical Industries Latest Developments
Table 125. Bama-Geve, SLU Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Bama-Geve, SLU IBS-C Drugs Product Portfolios and Specifications
Table 127. Bama-Geve, SLU IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Bama-Geve, SLU Main Business
Table 129. Bama-Geve, SLU Latest Developments
Table 130. Ferring BV Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. Ferring BV IBS-C Drugs Product Portfolios and Specifications
Table 132. Ferring BV IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Ferring BV Main Business
Table 134. Ferring BV Latest Developments
Table 135. Ironwood Pharmaceuticals, Inc Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. Ironwood Pharmaceuticals, Inc IBS-C Drugs Product Portfolios and Specifications
Table 137. Ironwood Pharmaceuticals, Inc IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 138. Ironwood Pharmaceuticals, Inc Main Business
Table 139. Ironwood Pharmaceuticals, Inc Latest Developments
Table 140. Salix Pharmaceuticals Ltd Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 141. Salix Pharmaceuticals Ltd IBS-C Drugs Product Portfolios and Specifications
Table 142. Salix Pharmaceuticals Ltd IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 143. Salix Pharmaceuticals Ltd Main Business
Table 144. Salix Pharmaceuticals Ltd Latest Developments
Table 145. Norgine B.V Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 146. Norgine B.V IBS-C Drugs Product Portfolios and Specifications
Table 147. Norgine B.V IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 148. Norgine B.V Main Business
Table 149. Norgine B.V Latest Developments
Table 150. Prometheus Laboratories Inc Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 151. Prometheus Laboratories Inc IBS-C Drugs Product Portfolios and Specifications
Table 152. Prometheus Laboratories Inc IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 153. Prometheus Laboratories Inc Main Business
Table 154. Prometheus Laboratories Inc Latest Developments
Table 155. Actavis Nordic A/S Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 156. Actavis Nordic A/S IBS-C Drugs Product Portfolios and Specifications
Table 157. Actavis Nordic A/S IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 158. Actavis Nordic A/S Main Business
Table 159. Actavis Nordic A/S Latest Developments
Table 160. Albireo Pharma Inc Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 161. Albireo Pharma Inc IBS-C Drugs Product Portfolios and Specifications
Table 162. Albireo Pharma Inc IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 163. Albireo Pharma Inc Main Business
Table 164. Albireo Pharma Inc Latest Developments
Table 165. Yuhan Corp Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 166. Yuhan Corp IBS-C Drugs Product Portfolios and Specifications
Table 167. Yuhan Corp IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 168. Yuhan Corp Main Business
Table 169. Yuhan Corp Latest Developments
Table 170. Astrazeneca Plc Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 171. Astrazeneca Plc IBS-C Drugs Product Portfolios and Specifications
Table 172. Astrazeneca Plc IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 173. Astrazeneca Plc Main Business
Table 174. Astrazeneca Plc Latest Developments
Table 175. The Menarini Group Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 176. The Menarini Group IBS-C Drugs Product Portfolios and Specifications
Table 177. The Menarini Group IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 178. The Menarini Group Main Business
Table 179. The Menarini Group Latest Developments
Table 180. Ono Pharmaceutical Co., Ltd Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 181. Ono Pharmaceutical Co., Ltd IBS-C Drugs Product Portfolios and Specifications
Table 182. Ono Pharmaceutical Co., Ltd IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 183. Ono Pharmaceutical Co., Ltd Main Business
Table 184. Ono Pharmaceutical Co., Ltd Latest Developments
Table 1. IBS-C Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. IBS-C Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Linaclotide
Table 4. Major Players of Lubiprostone
Table 5. Major Players of Osmotic Laxatives
Table 6. Major Players of Stimulant Laxatives
Table 7. Major Players of Others
Table 8. Global IBS-C Drugs Sales by Type (2020-2025) & (K Pcs)
Table 9. Global IBS-C Drugs Sales Market Share by Type (2020-2025)
Table 10. Global IBS-C Drugs Revenue by Type (2020-2025) & ($ million)
Table 11. Global IBS-C Drugs Revenue Market Share by Type (2020-2025)
Table 12. Global IBS-C Drugs Sale Price by Type (2020-2025) & (USD/Pcs)
Table 13. Global IBS-C Drugs Sale by Application (2020-2025) & (K Pcs)
Table 14. Global IBS-C Drugs Sale Market Share by Application (2020-2025)
Table 15. Global IBS-C Drugs Revenue by Application (2020-2025) & ($ million)
Table 16. Global IBS-C Drugs Revenue Market Share by Application (2020-2025)
Table 17. Global IBS-C Drugs Sale Price by Application (2020-2025) & (USD/Pcs)
Table 18. Global IBS-C Drugs Sales by Company (2020-2025) & (K Pcs)
Table 19. Global IBS-C Drugs Sales Market Share by Company (2020-2025)
Table 20. Global IBS-C Drugs Revenue by Company (2020-2025) & ($ millions)
Table 21. Global IBS-C Drugs Revenue Market Share by Company (2020-2025)
Table 22. Global IBS-C Drugs Sale Price by Company (2020-2025) & (USD/Pcs)
Table 23. Key Manufacturers IBS-C Drugs Producing Area Distribution and Sales Area
Table 24. Players IBS-C Drugs Products Offered
Table 25. IBS-C Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global IBS-C Drugs Sales by Geographic Region (2020-2025) & (K Pcs)
Table 29. Global IBS-C Drugs Sales Market Share Geographic Region (2020-2025)
Table 30. Global IBS-C Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global IBS-C Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global IBS-C Drugs Sales by Country/Region (2020-2025) & (K Pcs)
Table 33. Global IBS-C Drugs Sales Market Share by Country/Region (2020-2025)
Table 34. Global IBS-C Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global IBS-C Drugs Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas IBS-C Drugs Sales by Country (2020-2025) & (K Pcs)
Table 37. Americas IBS-C Drugs Sales Market Share by Country (2020-2025)
Table 38. Americas IBS-C Drugs Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas IBS-C Drugs Sales by Type (2020-2025) & (K Pcs)
Table 40. Americas IBS-C Drugs Sales by Application (2020-2025) & (K Pcs)
Table 41. APAC IBS-C Drugs Sales by Region (2020-2025) & (K Pcs)
Table 42. APAC IBS-C Drugs Sales Market Share by Region (2020-2025)
Table 43. APAC IBS-C Drugs Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC IBS-C Drugs Sales by Type (2020-2025) & (K Pcs)
Table 45. APAC IBS-C Drugs Sales by Application (2020-2025) & (K Pcs)
Table 46. Europe IBS-C Drugs Sales by Country (2020-2025) & (K Pcs)
Table 47. Europe IBS-C Drugs Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe IBS-C Drugs Sales by Type (2020-2025) & (K Pcs)
Table 49. Europe IBS-C Drugs Sales by Application (2020-2025) & (K Pcs)
Table 50. Middle East & Africa IBS-C Drugs Sales by Country (2020-2025) & (K Pcs)
Table 51. Middle East & Africa IBS-C Drugs Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa IBS-C Drugs Sales by Type (2020-2025) & (K Pcs)
Table 53. Middle East & Africa IBS-C Drugs Sales by Application (2020-2025) & (K Pcs)
Table 54. Key Market Drivers & Growth Opportunities of IBS-C Drugs
Table 55. Key Market Challenges & Risks of IBS-C Drugs
Table 56. Key Industry Trends of IBS-C Drugs
Table 57. IBS-C Drugs Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. IBS-C Drugs Distributors List
Table 60. IBS-C Drugs Customer List
Table 61. Global IBS-C Drugs Sales Forecast by Region (2026-2031) & (K Pcs)
Table 62. Global IBS-C Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas IBS-C Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
Table 64. Americas IBS-C Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC IBS-C Drugs Sales Forecast by Region (2026-2031) & (K Pcs)
Table 66. APAC IBS-C Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe IBS-C Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Europe IBS-C Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa IBS-C Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
Table 70. Middle East & Africa IBS-C Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global IBS-C Drugs Sales Forecast by Type (2026-2031) & (K Pcs)
Table 72. Global IBS-C Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global IBS-C Drugs Sales Forecast by Application (2026-2031) & (K Pcs)
Table 74. Global IBS-C Drugs Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Catalent Pharmaceuticals Solutions Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 76. Catalent Pharmaceuticals Solutions IBS-C Drugs Product Portfolios and Specifications
Table 77. Catalent Pharmaceuticals Solutions IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Catalent Pharmaceuticals Solutions Main Business
Table 79. Catalent Pharmaceuticals Solutions Latest Developments
Table 80. Nestle Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Nestle IBS-C Drugs Product Portfolios and Specifications
Table 82. Nestle IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Nestle Main Business
Table 84. Nestle Latest Developments
Table 85. Abbott Laboratories Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Abbott Laboratories IBS-C Drugs Product Portfolios and Specifications
Table 87. Abbott Laboratories IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Abbott Laboratories Main Business
Table 89. Abbott Laboratories Latest Developments
Table 90. Synergy Pharmaceuticals Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Synergy Pharmaceuticals IBS-C Drugs Product Portfolios and Specifications
Table 92. Synergy Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Synergy Pharmaceuticals Main Business
Table 94. Synergy Pharmaceuticals Latest Developments
Table 95. Sucampo Pharmaceuticals Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Sucampo Pharmaceuticals IBS-C Drugs Product Portfolios and Specifications
Table 97. Sucampo Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Sucampo Pharmaceuticals Main Business
Table 99. Sucampo Pharmaceuticals Latest Developments
Table 100. Novartis Pharma Ag Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Novartis Pharma Ag IBS-C Drugs Product Portfolios and Specifications
Table 102. Novartis Pharma Ag IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Novartis Pharma Ag Main Business
Table 104. Novartis Pharma Ag Latest Developments
Table 105. Astellas Pharmaceuticals Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Astellas Pharmaceuticals IBS-C Drugs Product Portfolios and Specifications
Table 107. Astellas Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Astellas Pharmaceuticals Main Business
Table 109. Astellas Pharmaceuticals Latest Developments
Table 110. Ardelyx, Inc Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Ardelyx, Inc IBS-C Drugs Product Portfolios and Specifications
Table 112. Ardelyx, Inc IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Ardelyx, Inc Main Business
Table 114. Ardelyx, Inc Latest Developments
Table 115. Synthetic Biologics, Inc Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Synthetic Biologics, Inc IBS-C Drugs Product Portfolios and Specifications
Table 117. Synthetic Biologics, Inc IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Synthetic Biologics, Inc Main Business
Table 119. Synthetic Biologics, Inc Latest Developments
Table 120. Teva Pharmaceutical Industries Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Teva Pharmaceutical Industries IBS-C Drugs Product Portfolios and Specifications
Table 122. Teva Pharmaceutical Industries IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Teva Pharmaceutical Industries Main Business
Table 124. Teva Pharmaceutical Industries Latest Developments
Table 125. Bama-Geve, SLU Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Bama-Geve, SLU IBS-C Drugs Product Portfolios and Specifications
Table 127. Bama-Geve, SLU IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Bama-Geve, SLU Main Business
Table 129. Bama-Geve, SLU Latest Developments
Table 130. Ferring BV Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. Ferring BV IBS-C Drugs Product Portfolios and Specifications
Table 132. Ferring BV IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Ferring BV Main Business
Table 134. Ferring BV Latest Developments
Table 135. Ironwood Pharmaceuticals, Inc Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. Ironwood Pharmaceuticals, Inc IBS-C Drugs Product Portfolios and Specifications
Table 137. Ironwood Pharmaceuticals, Inc IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 138. Ironwood Pharmaceuticals, Inc Main Business
Table 139. Ironwood Pharmaceuticals, Inc Latest Developments
Table 140. Salix Pharmaceuticals Ltd Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 141. Salix Pharmaceuticals Ltd IBS-C Drugs Product Portfolios and Specifications
Table 142. Salix Pharmaceuticals Ltd IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 143. Salix Pharmaceuticals Ltd Main Business
Table 144. Salix Pharmaceuticals Ltd Latest Developments
Table 145. Norgine B.V Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 146. Norgine B.V IBS-C Drugs Product Portfolios and Specifications
Table 147. Norgine B.V IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 148. Norgine B.V Main Business
Table 149. Norgine B.V Latest Developments
Table 150. Prometheus Laboratories Inc Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 151. Prometheus Laboratories Inc IBS-C Drugs Product Portfolios and Specifications
Table 152. Prometheus Laboratories Inc IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 153. Prometheus Laboratories Inc Main Business
Table 154. Prometheus Laboratories Inc Latest Developments
Table 155. Actavis Nordic A/S Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 156. Actavis Nordic A/S IBS-C Drugs Product Portfolios and Specifications
Table 157. Actavis Nordic A/S IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 158. Actavis Nordic A/S Main Business
Table 159. Actavis Nordic A/S Latest Developments
Table 160. Albireo Pharma Inc Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 161. Albireo Pharma Inc IBS-C Drugs Product Portfolios and Specifications
Table 162. Albireo Pharma Inc IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 163. Albireo Pharma Inc Main Business
Table 164. Albireo Pharma Inc Latest Developments
Table 165. Yuhan Corp Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 166. Yuhan Corp IBS-C Drugs Product Portfolios and Specifications
Table 167. Yuhan Corp IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 168. Yuhan Corp Main Business
Table 169. Yuhan Corp Latest Developments
Table 170. Astrazeneca Plc Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 171. Astrazeneca Plc IBS-C Drugs Product Portfolios and Specifications
Table 172. Astrazeneca Plc IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 173. Astrazeneca Plc Main Business
Table 174. Astrazeneca Plc Latest Developments
Table 175. The Menarini Group Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 176. The Menarini Group IBS-C Drugs Product Portfolios and Specifications
Table 177. The Menarini Group IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 178. The Menarini Group Main Business
Table 179. The Menarini Group Latest Developments
Table 180. Ono Pharmaceutical Co., Ltd Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors
Table 181. Ono Pharmaceutical Co., Ltd IBS-C Drugs Product Portfolios and Specifications
Table 182. Ono Pharmaceutical Co., Ltd IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 183. Ono Pharmaceutical Co., Ltd Main Business
Table 184. Ono Pharmaceutical Co., Ltd Latest Developments
LIST OF FIGURES
Figure 1. Picture of IBS-C Drugs
Figure 2. IBS-C Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global IBS-C Drugs Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global IBS-C Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. IBS-C Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. IBS-C Drugs Sales Market Share by Country/Region (2024)
Figure 10. IBS-C Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Linaclotide
Figure 12. Product Picture of Lubiprostone
Figure 13. Product Picture of Osmotic Laxatives
Figure 14. Product Picture of Stimulant Laxatives
Figure 15. Product Picture of Others
Figure 16. Global IBS-C Drugs Sales Market Share by Type in 2025
Figure 17. Global IBS-C Drugs Revenue Market Share by Type (2020-2025)
Figure 18. IBS-C Drugs Consumed in Hospital Pharmacies
Figure 19. Global IBS-C Drugs Market: Hospital Pharmacies (2020-2025) & (K Pcs)
Figure 20. IBS-C Drugs Consumed in Retail Pharmacies
Figure 21. Global IBS-C Drugs Market: Retail Pharmacies (2020-2025) & (K Pcs)
Figure 22. IBS-C Drugs Consumed in Online Pharmacies
Figure 23. Global IBS-C Drugs Market: Online Pharmacies (2020-2025) & (K Pcs)
Figure 24. Global IBS-C Drugs Sale Market Share by Application (2024)
Figure 25. Global IBS-C Drugs Revenue Market Share by Application in 2025
Figure 26. IBS-C Drugs Sales by Company in 2025 (K Pcs)
Figure 27. Global IBS-C Drugs Sales Market Share by Company in 2025
Figure 28. IBS-C Drugs Revenue by Company in 2025 ($ millions)
Figure 29. Global IBS-C Drugs Revenue Market Share by Company in 2025
Figure 30. Global IBS-C Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global IBS-C Drugs Revenue Market Share by Geographic Region in 2025
Figure 32. Americas IBS-C Drugs Sales 2020-2025 (K Pcs)
Figure 33. Americas IBS-C Drugs Revenue 2020-2025 ($ millions)
Figure 34. APAC IBS-C Drugs Sales 2020-2025 (K Pcs)
Figure 35. APAC IBS-C Drugs Revenue 2020-2025 ($ millions)
Figure 36. Europe IBS-C Drugs Sales 2020-2025 (K Pcs)
Figure 37. Europe IBS-C Drugs Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa IBS-C Drugs Sales 2020-2025 (K Pcs)
Figure 39. Middle East & Africa IBS-C Drugs Revenue 2020-2025 ($ millions)
Figure 40. Americas IBS-C Drugs Sales Market Share by Country in 2025
Figure 41. Americas IBS-C Drugs Revenue Market Share by Country (2020-2025)
Figure 42. Americas IBS-C Drugs Sales Market Share by Type (2020-2025)
Figure 43. Americas IBS-C Drugs Sales Market Share by Application (2020-2025)
Figure 44. United States IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC IBS-C Drugs Sales Market Share by Region in 2025
Figure 49. APAC IBS-C Drugs Revenue Market Share by Region (2020-2025)
Figure 50. APAC IBS-C Drugs Sales Market Share by Type (2020-2025)
Figure 51. APAC IBS-C Drugs Sales Market Share by Application (2020-2025)
Figure 52. China IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. India IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe IBS-C Drugs Sales Market Share by Country in 2025
Figure 60. Europe IBS-C Drugs Revenue Market Share by Country (2020-2025)
Figure 61. Europe IBS-C Drugs Sales Market Share by Type (2020-2025)
Figure 62. Europe IBS-C Drugs Sales Market Share by Application (2020-2025)
Figure 63. Germany IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. France IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. UK IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa IBS-C Drugs Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa IBS-C Drugs Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa IBS-C Drugs Sales Market Share by Application (2020-2025)
Figure 71. Egypt IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of IBS-C Drugs in 2025
Figure 77. Manufacturing Process Analysis of IBS-C Drugs
Figure 78. Industry Chain Structure of IBS-C Drugs
Figure 79. Channels of Distribution
Figure 80. Global IBS-C Drugs Sales Market Forecast by Region (2026-2031)
Figure 81. Global IBS-C Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global IBS-C Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global IBS-C Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global IBS-C Drugs Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global IBS-C Drugs Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of IBS-C Drugs
Figure 2. IBS-C Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global IBS-C Drugs Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global IBS-C Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. IBS-C Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. IBS-C Drugs Sales Market Share by Country/Region (2024)
Figure 10. IBS-C Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Linaclotide
Figure 12. Product Picture of Lubiprostone
Figure 13. Product Picture of Osmotic Laxatives
Figure 14. Product Picture of Stimulant Laxatives
Figure 15. Product Picture of Others
Figure 16. Global IBS-C Drugs Sales Market Share by Type in 2025
Figure 17. Global IBS-C Drugs Revenue Market Share by Type (2020-2025)
Figure 18. IBS-C Drugs Consumed in Hospital Pharmacies
Figure 19. Global IBS-C Drugs Market: Hospital Pharmacies (2020-2025) & (K Pcs)
Figure 20. IBS-C Drugs Consumed in Retail Pharmacies
Figure 21. Global IBS-C Drugs Market: Retail Pharmacies (2020-2025) & (K Pcs)
Figure 22. IBS-C Drugs Consumed in Online Pharmacies
Figure 23. Global IBS-C Drugs Market: Online Pharmacies (2020-2025) & (K Pcs)
Figure 24. Global IBS-C Drugs Sale Market Share by Application (2024)
Figure 25. Global IBS-C Drugs Revenue Market Share by Application in 2025
Figure 26. IBS-C Drugs Sales by Company in 2025 (K Pcs)
Figure 27. Global IBS-C Drugs Sales Market Share by Company in 2025
Figure 28. IBS-C Drugs Revenue by Company in 2025 ($ millions)
Figure 29. Global IBS-C Drugs Revenue Market Share by Company in 2025
Figure 30. Global IBS-C Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global IBS-C Drugs Revenue Market Share by Geographic Region in 2025
Figure 32. Americas IBS-C Drugs Sales 2020-2025 (K Pcs)
Figure 33. Americas IBS-C Drugs Revenue 2020-2025 ($ millions)
Figure 34. APAC IBS-C Drugs Sales 2020-2025 (K Pcs)
Figure 35. APAC IBS-C Drugs Revenue 2020-2025 ($ millions)
Figure 36. Europe IBS-C Drugs Sales 2020-2025 (K Pcs)
Figure 37. Europe IBS-C Drugs Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa IBS-C Drugs Sales 2020-2025 (K Pcs)
Figure 39. Middle East & Africa IBS-C Drugs Revenue 2020-2025 ($ millions)
Figure 40. Americas IBS-C Drugs Sales Market Share by Country in 2025
Figure 41. Americas IBS-C Drugs Revenue Market Share by Country (2020-2025)
Figure 42. Americas IBS-C Drugs Sales Market Share by Type (2020-2025)
Figure 43. Americas IBS-C Drugs Sales Market Share by Application (2020-2025)
Figure 44. United States IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC IBS-C Drugs Sales Market Share by Region in 2025
Figure 49. APAC IBS-C Drugs Revenue Market Share by Region (2020-2025)
Figure 50. APAC IBS-C Drugs Sales Market Share by Type (2020-2025)
Figure 51. APAC IBS-C Drugs Sales Market Share by Application (2020-2025)
Figure 52. China IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. India IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe IBS-C Drugs Sales Market Share by Country in 2025
Figure 60. Europe IBS-C Drugs Revenue Market Share by Country (2020-2025)
Figure 61. Europe IBS-C Drugs Sales Market Share by Type (2020-2025)
Figure 62. Europe IBS-C Drugs Sales Market Share by Application (2020-2025)
Figure 63. Germany IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. France IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. UK IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa IBS-C Drugs Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa IBS-C Drugs Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa IBS-C Drugs Sales Market Share by Application (2020-2025)
Figure 71. Egypt IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries IBS-C Drugs Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of IBS-C Drugs in 2025
Figure 77. Manufacturing Process Analysis of IBS-C Drugs
Figure 78. Industry Chain Structure of IBS-C Drugs
Figure 79. Channels of Distribution
Figure 80. Global IBS-C Drugs Sales Market Forecast by Region (2026-2031)
Figure 81. Global IBS-C Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global IBS-C Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global IBS-C Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global IBS-C Drugs Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global IBS-C Drugs Revenue Market Share Forecast by Application (2026-2031)
